• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    S

    Signature Research (United States)

    企业EST. 1992
    32论文总数
    629引用总数

    论文量&引用量时间轴

    机构学者

    论文(32)

    年份
    起
    –
    止
    排序
    1Longitudinal Assessment from Liquid Biopsy of Mutations in CD20: A Pilot Study Using a PETE Enrichment Strategy.
    Tyler Landrith, Linlin Cao, Samantha Smith, Ruben Van Der Merwe, Corinna Lutterbeck,Carmelo Carlo-Stella,Michael Dickinson,Martin Hutchings, Ulrich Schlecht, Antonio Sorrentino, Wei Yang,Patrick Bogard,

    7042 Background: In recent years, bispecific T cell Engagers (BsTCE) targeting CD3 and CD20 have emerged as a potent new class of therapeutics for NHL; however, a subset of patients still experience relapsed or refractory disease. Patients undergoing treatment with BsTCEs could benefit from longitudinal screening via liquid biopsy to identify baseline (primary) and treatment-induced (acquired) resistance mutations and tailor treatment accordingly. Here we present the results from a pilot study screening patients treated with Glofitamab (CD20xCD3) using a single gene Primer Extension Target Enrichment (PETE) strategy for MS4A1 (CD20 gene) in liquid biopsies. Methods: Our pilot study was conducted using libraries from the plasma of 134/155 patients with relapsed or refractory large B cell lymphoma (r/r LBCL) who underwent Glofitamab treatment at approved dose in the phase I/II trial NP30179 ( NCT03075696 ) (Dickinson, et al. N Engl J Med 2022), and paired PBMC/PDB available in 91 cases. Primers were designed against the coding regions of the MS4A1 gene. Enrichment was performed using a workflow optimized for the detection of somatic variants in cell-free DNA isolated from plasma. Results were analyzed using a modified AVENIO circulating tumor (ct) DNA (Roche; For Research Use Only) analysis workflow. Variants detected by the analysis pipeline were further filtered based on inclusion criteria: allele fraction > 0.1%, rarity in the cohort, impact on protein function in silico , and if sample was available, absence in germline. Tumor burden as assessed by ctDNA was obtained from retrospective sequencing data. Response to treatment was assessed by PET/CT using the Lugano Criteria. Results: Using inclusion criteria a total of 11/134 (8.2%) patients were identified with a total of 16 unique MS4A1 candidate mutations at baseline or during treatment. The Best Overall Investigator Response (BOR) was progressive disease (PD) for 7 patients and partial metabolic response (PR) for 4 patients. All patients with BOR PR experienced disease progression before treatment completion. Sufficient samples were available to demonstrate expansion of the candidate mutation by the end of treatment (EOT) timepoint for 5 patients. Four of the identified mutations were previously reported in the literature, the remaining mutations were novel, and in vitro characterization demonstrated their functional impact. Conclusions: This work identifies known and novel mutations in CD20 in plasma samples as a potential contributing mechanism to relapsed or refractory cases of NHL. Although the prevalence appears to be low, this is consistent with previous reports and supports investigation of the clinical utility, including utility as a potential predictive biomarker, of sequencing this gene during treatment with CD20xCD3 BsTCE. Future and ongoing work will screen additional cohorts and therapy combinations.

    2025JOURNAL OF CLINICAL ONCOLOGY(2025)
    引用
    AI阅读
    加入学术空间
    2Synthetic Augmentation Methods for Object Detection in Infrared Overhead Imagery
    Nicholas Hamilton,Adam Webb, Matt Wilder, Ben Hendrickson, Matthew Blanck,Erin Nelson, Wiley Roemer,Timothy C. Havens

    Geospatial intelligence is a subject with many opportunities for machine automation. Object detection is one desirable application. However, a lack of high-volume relevant datasets can make this task difficult. To combat this issue, we introduced a spin-set augmentation technique to generate synthetic training data. We used these synthetic datasets to augment the training of an object detection deep network, focusing on visible band imagery. We have continued our efforts by further testing this method on long-wave infrared imagery, including results from YOLO, SSD, and Faster R-CNN algorithms. We also introduce another synthetic augmentation technique which involves generating physics-based fully-rendered images of 3D synthetic scenery and targets and compared the rendered image performance to that of spin-sets. This paper analyzes both the spin-set and rendered image augmentation techniques in terms of object detection performance, complexity, generalizability, and explainability.

    2024
    引用
    AI阅读
    加入学术空间
    3Comparison of Results from Two Commercially Available In-house Tissue-Based Comprehensive Genomic Profiling Solutions: Research Use Only AVENIO Tumor Tissue CGP (AVENIO CGP) Kit and TruSight Oncology 500 (TSO-500) Assay
    Hans-Peter Adams, Matthew Hiemenz, K. Hertel, Frederike Fuhlbrück, Mara Thomas, James Oughton, Helle Sørensen, Ulrich Schlecht,Justin M. Allen, Martina Cantone, Stefan Osswald,David González,

    Increased adoption of personalized medicine has brought comprehensive genomic profiling (CGP) to the forefront. However, differences in assay, bioinformatics, and reporting systems and lack of understanding of their complex interplay are a challenge for implementation and achieving uniformity in CGP testing. Two commercially available, tissue-based, in-house CGP assays were compared, in combination with a tertiary analysis solution in a research-use only (RUO) context: the AVENIO Tumor Tissue CGP RUO Kit paired with navify Mutation Profiler (RUO) software and the TruSight Oncology 500 RUO assay paired with PierianDx Clinical Genomics Workspace software. Agreements and differences between the assays were assessed for short variants, copy number alterations, rearrangements, tumor mutational burden, and microsatellite instability, including variant categorization and clinical trial-matching (CTM) recommendations. Results showed good overall agreement for short variant, known gene fusion, and microsatellite instability detection. Important differences were obtained in tumor mutational burden scoring, copy number alteration detection, and CTM. Differences in variant and biomarker detection could be explained by bioinformatic approaches to variant calling, filtering, tiering, and normalization; differences in CTM, by underlying reported variants and conceptual differences in system parameters. Thus, distinctions between different approaches may lead to inconsistent results. Complexities in calling, filtering, and interpreting variants illustrate key considerations for implementation of any high-quality CGP in the laboratory and bringing uniformity to genomic insight results.

    2024Journal of Molecular Diagnostics(2024)
    引用
    AI阅读
    加入学术空间
    4A Study of the Effect of Family Relation (parent’s Acceptance and Rejection) of Physically Handicapped Adolescent Boys and Girls on Self – Actualisation
    Archana Paliwal, Rahul Patel, Vaibhav Murhar, B. Nigam

    The investigation focused on effect of family relation on self - actualization of physically handicapped adolescent boys and girls. 240 boys and girls selected on the basis of family relation through multistage sampling in each group are compared through analysis of variance. Significant effect of parent child relation & personality variables is noted.

    2023International Journal of Social Science and Human Research(2023)
    引用
    AI阅读
    加入学术空间
    5Personalised Medicine, Including Pharmacogenetics
    Houwaida Abbes,Yassine Khalij, Mohamed Ajmi,Amira Moussa, A. Meddeb, Mehdi Slim, Asma Omezzine, Ali Bouslema,Amani Abderahmene, David J. Amor,W. Sahtout,D. Zellama,

    BACKGROUND-AIMStatins, a class of lipid lowering medications are the keystone treatment in the primary and secondary prevention of cardiovascular disease.Nevertheless they show a significant inter-individual variability in terms of efficacy and safety.This variability is related to various factors including genetic factors.We are interested in studying eight polymophisms.

    2021Clinical Chemistry and Laboratory Medicine (CCLM)(2021)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 32 篇论文

    合作机构(54)

    密歇根科技大学合作论文 2
    德克萨斯大学奥斯汀分校合作论文 2
    Materials Systems (United States)合作论文 1
    Hospital Universitario Son Espases合作论文 1
    犹他大学合作论文 1
    哥廷根大学合作论文 1
    Düsseldorf University Hospital合作论文 1
    Saint Vincent's Catholic Medical Centers合作论文 1
    University of the West Indies System合作论文 1
    罗玛琳达大学合作论文 1

    机构统计